Grønborg M, Wulff B S, Rasmussen J S, Kjeldsen T, Gammeltoft S
Department of Clinical Chemistry, Bispebjerg Hospital, Copenhagen, Denmark.
J Biol Chem. 1993 Nov 5;268(31):23435-40.
Insulin-like growth factor I (IGF-I) and insulin receptors are structurally similar with ligand-stimulated tyrosine kinase activity in their cytoplasmic domains. The function of the insulin receptor tyrosine kinase in signal transduction has been studied extensively in contrast to the IGF-I receptor tyrosine kinase. In the present study we have analyzed the regulatory function of the IGF-I receptor tyrosine kinase and carboxyl-terminal domains in mitogenic signaling by overexpression of mutant IGF-I receptors in mouse NIH-3T3 fibroblasts. A mutant IGF-I receptor, in which 3 tyrosines (Tyr1131, Tyr1135, and Tyr1136) analogous to the three major autophosphorylation sites in the insulin receptor kinase were replaced by phenylalanines, was devoid of kinase activity in vivo and in vitro and inactive with respect to IGF-I internalization and stimulation of thymidine incorporation. Another mutant IGF-I receptor, which lacks the 49 carboxyl-terminal amino acids (residues 1289-1337) of the beta-subunit, was fully active. Our data suggest that the structure-function relationship of the IGF-I receptor tyrosine kinase activation and signal transduction is similar to that of the insulin receptor.
胰岛素样生长因子I(IGF-I)受体和胰岛素受体在结构上相似,其胞质结构域具有配体刺激的酪氨酸激酶活性。与IGF-I受体酪氨酸激酶相比,胰岛素受体酪氨酸激酶在信号转导中的功能已得到广泛研究。在本研究中,我们通过在小鼠NIH-3T3成纤维细胞中过表达突变型IGF-I受体,分析了IGF-I受体酪氨酸激酶和羧基末端结构域在有丝分裂信号传导中的调节功能。一种突变型IGF-I受体,其中与胰岛素受体激酶的三个主要自磷酸化位点类似的3个酪氨酸(Tyr1131、Tyr1135和Tyr1136)被苯丙氨酸取代,在体内和体外均无激酶活性,并且在IGF-I内化和刺激胸苷掺入方面无活性。另一种突变型IGF-I受体,其β亚基缺少49个羧基末端氨基酸(第1289 - 1337位氨基酸残基),具有完全活性。我们的数据表明,IGF-I受体酪氨酸激酶激活和信号转导的结构-功能关系与胰岛素受体相似。